Cytori to Present at the Noble Financial Equity Conference on August 18

Cytori Therapeutics 2nd Quarter Results Conference Call to Begin at 10:30 AM

Cytori to Raise $17 Million in Private Placement with Olympus and Institutional Investors

Cytori Reports Second Quarter Financial Results; Strong Growth in Product Orders and Celution(R) Revenue

Cytori Therapeutics to Webcast 2nd Quarter Results on August 8, 2008

Cytori Enters Binding Letter of Intent for StemSource(R) Cell Bank Sales for Singapore

Cytori Receives U.S. Patent Allowance for Protecting Cosmetic & Reconstructive Surgery Product Line

Cytori Sells First European Union StemSource(R) Bank; Industry Leading Biohellenika of Greece Acquires Exclusive Rights

U.S. Patent on Cytori's Celution(R) System Technology Issued; Celution(R) System Commercialization not Impacted by Recent 6,777,231 Patent Inventorship Decision

Cytori Set to Join Russell 3000 Index

Cytori Selected by Fraunhofer Society to Develop New Stem and Regenerative Cell-Based Treatments for Stroke

University of California Loses Rights to '231 Patent Licensed to Cytori; Ruling Unrelated to Celution(R) System Family of Products

Cytori Receives Patent on Core Celution(R) System Technology

Cytori and Green Hospital Supply Expand StemSource(R) Cell Bank Commercialization Partnership

SectorWatch.biz Issues MarketStats on CYTX, HNSN, MDT, SYK, and JNJ

Three Month Results Reported from Stem & Regenerative Cell Breast Augmentation Study

Cytori to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

Cytori Reports First Celution(R) System Revenues During the First Quarter; Provides Update on Celution(R) System Commercialization

Cytori Begins Breast Reconstruction Study in Europe

Cytori Closes 2nd Half of $12 Million Equity Agreement with Green Hospital Supply

Cytori Therapeutics to Webcast 1st Quarter Results on May 9, 2008

Nagasaki University Awarded Clinical Research Grant to Study Cell-Enhanced Reconstruction in HIV Therapy-Induced Facial Atrophy Using Celution(R) 800 System

Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell Breast Augmentation Study in Japan